US Patent 11325914 Inhibitors of cellular metabolic processes
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Dec, 2023
Golden AI
Edits made to:
Article (+196 characters)
Article
Patent abstract
The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA):
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
113259140
Date of Patent
May 10, 2022
0Patent Application Number
170004110
Date Filed
August 24, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
113259140
Date of Patent
May 10, 2022
0Patent Application Number
170004110
Date Filed
August 24, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 11325914 Inhibitors of cellular metabolic processes
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
11325914
Date of patent
May 10, 2022
Patent application number
17000411
Date Filed
August 24, 2020
Patent citations
Patent primary examiner
CPC Code
Find more entities like US Patent 11325914 Inhibitors of cellular metabolic processes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.